BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31936544)

  • 21. A Comparative Study on Anti-Invasion, Antimigration, and Antiadhesion Effects of the Bioactive Carotenoids of Saffron on 4T1 Breast Cancer Cells Through Their Effects on Wnt/β-Catenin Pathway Genes.
    Arzi L; Riazi G; Sadeghizadeh M; Hoshyar R; Jafarzadeh N
    DNA Cell Biol; 2018 Aug; 37(8):697-707. PubMed ID: 29969282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation, chemical characterization and determination of crocetin's pharmacokinetics after oral and intravenous administration of saffron (Crocus sativus L.) aqueous extract to C57/BL6J mice.
    Christodoulou E; Grafakou ME; Skaltsa E; Kadoglou N; Kostomitsopoulos N; Valsami G
    J Pharm Pharmacol; 2019 May; 71(5):753-764. PubMed ID: 30575029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crocetin, a carotenoid derived from saffron (Crocus sativus L.), improves acetylcholine-induced vascular relaxation in hypertension.
    Mancini A; Serrano-Díaz J; Nava E; D'Alessandro AM; Alonso GL; Carmona M; Llorens S
    J Vasc Res; 2014; 51(5):393-404. PubMed ID: 25531977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Signal Pathways Involved in Crocetin-Induced Apoptosis in KYSE-150 Cells.
    Li S; Qu Y; Shen XY; Ouyang T; Fu WB; Luo T; Wang HQ
    Pharmacology; 2019; 103(5-6):263-272. PubMed ID: 30783055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer.
    Bathaie SZ; Hoshyar R; Miri H; Sadeghizadeh M
    Biochem Cell Biol; 2013 Dec; 91(6):397-403. PubMed ID: 24219281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saffron ameliorated motor symptoms, short life span and retinal degeneration in Parkinson's disease fly models.
    Inoue E; Suzuki T; Shimizu Y; Sudo K; Kawasaki H; Ishida N
    Gene; 2021 Oct; 799():145811. PubMed ID: 34224829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
    Avril T; Etcheverry A; Pineau R; Obacz J; Jegou G; Jouan F; Le Reste PJ; Hatami M; Colen RR; Carlson BL; Decker PA; Sarkaria JN; Vauléon E; Chiforeanu DC; Clavreul A; Mosser J; Chevet E; Quillien V
    Clin Cancer Res; 2017 Dec; 23(23):7360-7374. PubMed ID: 28939749
    [No Abstract]   [Full Text] [Related]  

  • 33. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas.
    Shi L; Sun G; Zhang Y
    Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.
    Motaln H; Koren A; Gruden K; Ramšak Ž; Schichor C; Lah TT
    Oncotarget; 2015 Dec; 6(38):40998-1017. PubMed ID: 26517510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
    Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
    Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effect of crocin and crocetin, two major compounds extracted from saffron, on osteogenic differentiation of mesenchymal stem cells.
    Kalalinia F; Ghasim H; Amel Farzad S; Pishavar E; Ramezani M; Hashemi M
    Life Sci; 2018 Sep; 208():262-267. PubMed ID: 30048694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.